Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

RoosterBio Blog

Bridging the Chasm Between Ideation & Commercialization for Advanced Therapy Startups: How to Build Support in the Early Days of Entrepreneurship

May 31, 2023 BioEconomy

Listen to this Blog:  Cell therapy is a large and growing market, with industry analysts estimating a global market size of $22B in 2022 and a CAGR of 14.15% by 2030 (Grandview ... More

Mitochondria Transplantation Therapy – It’s Farther Along Than You Think

May 09, 2023 Cell Therapy, Genetic Engineering

 “The future is already here – it’s just not evenly distributed.”  -William Gibson The whole idea sounds a little fanciful, almost like something from Star Trek. However, it may ... More

Sidebar Navigation

  • BioEconomy
  • Biomanufacturing
  • Bioprinting & Biofabrication
  • Bioprocessing
  • Cell Therapy
  • Conference Highlights
  • Corporate
  • COVID-19
  • Exosomes / Extracellular Vesicles
  • Genetic Engineering
  • MSCs & Characterization
  • Quality & Regulatory
  • Tissue Engineering
#1 Most Popular Blogs 3D Culture Adipose MSCs Adult Stem Cells Advanced Therapies Analytics BioEconomy Biomanufacturing Biomaterials Bioprinting / Biofabrication Bioprocess Bioreactors Bone Marrow MSCs Cell Therapy Clinical Trials COVID-19 Democratizing Technology Exosomes / Extracellular Vesicles Fetal Bovine Serum Genetic Engineering GMP Manufacturing Mesenchymal Stem / Stromal Cells Regenerative Medicine Regulatory RoosterBio Standardization Tissue Engineering Umbilical Cord MSCs

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email